These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7522037)
61. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Komiya A; Suzuki H; Ueda T; Yatani R; Emi M; Ito H; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):245-53. PubMed ID: 8946206 [TBL] [Abstract][Full Text] [Related]
62. Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22. Ohgaki K; Iida A; Ogawa O; Kubota Y; Akimoto M; Emi M Genes Chromosomes Cancer; 1999 May; 25(1):1-5. PubMed ID: 10221333 [TBL] [Abstract][Full Text] [Related]
63. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Linnenbach AJ; Pressler LB; Seng BA; Kimmel BS; Tomaszewski JE; Malkowicz SB Hum Mol Genet; 1993 Sep; 2(9):1407-11. PubMed ID: 7902161 [TBL] [Abstract][Full Text] [Related]
64. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Chuaqui RF; Sanz-Ortega J; Vocke C; Linehan WM; Sanz-Esponera J; Zhuang Z; Emmert-Buck MR; Merino MJ Cancer Res; 1995 Nov; 55(21):4995-8. PubMed ID: 7585541 [TBL] [Abstract][Full Text] [Related]
65. [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q]. Latil A; Baron JC; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R Bull Cancer; 1995 Jul; 82(7):589-97. PubMed ID: 7549122 [TBL] [Abstract][Full Text] [Related]
66. 8pter-p23 deletion is associated with racial differences in prostate cancer outcome. Washburn JG; Wojno KJ; Dey J; Powell IJ; Macoska JA Clin Cancer Res; 2000 Dec; 6(12):4647-52. PubMed ID: 11156215 [TBL] [Abstract][Full Text] [Related]
67. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938 [TBL] [Abstract][Full Text] [Related]
69. Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. Zhou W; Goodman M; Lyles RH; Lim SD; Williams TY; Rusthoven KE; Mandel JS; Amin MB; Petros JA Prostate; 2004 Sep; 61(1):81-91. PubMed ID: 15287096 [TBL] [Abstract][Full Text] [Related]
70. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation. Chan KL; Lee JM; Guan XY; Fan ST; Ng IO Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350 [TBL] [Abstract][Full Text] [Related]
71. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412 [TBL] [Abstract][Full Text] [Related]
72. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Gao X; Porter AT; Honn KV Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930 [TBL] [Abstract][Full Text] [Related]
73. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Takle LA; Knowles MA Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800 [TBL] [Abstract][Full Text] [Related]
74. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma. el-Naggar AK; Lee MS; Wang G; Luna MA; Goepfert H; Batsakis JG Cancer; 1993 Aug; 72(3):881-6. PubMed ID: 8101470 [TBL] [Abstract][Full Text] [Related]
75. Genetic alteration mapping on chromosome 7 in primary breast cancer. Bièche I; Khodja A; Driouch K; Lidereau R Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778 [TBL] [Abstract][Full Text] [Related]
76. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung]. Shao S; Sun W; Zhang J; An Q; Xiao T; Yang P; Cheng S; Gao Y Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):740-2. PubMed ID: 12126542 [TBL] [Abstract][Full Text] [Related]
77. Identification and characterization of proximal 6q deletions in prostate cancer. Cooney KA; Wetzel JC; Consolino CM; Wojno KJ Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584 [TBL] [Abstract][Full Text] [Related]
78. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271 [TBL] [Abstract][Full Text] [Related]
79. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648 [TBL] [Abstract][Full Text] [Related]
80. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]